Total Payments
$31,044
2024 Payments
$1,557
Companies
40
Transactions
450
Medicare Patients
5,967
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$19,650 (63.3%)
Food & Beverage$8,792 (28.3%)
Travel$2,592 (8.3%)
Education$10.28 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $10,200 | 4 | 32.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,450 | 10 | 30.4% |
| Food and Beverage | $8,792 | 425 | 28.3% |
| Travel and Lodging | $2,592 | 10 | 8.3% |
| Education | $10.28 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $10,929 | 37 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $6,716 | 30 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $5,019 | 7 | $0 (2017) |
| ABBVIE INC. | $2,318 | 130 | $0 (2024) |
| Apollo Endosurgery US Inc | $1,324 | 6 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $741.93 | 45 | $0 (2024) |
| Janssen Biotech, Inc. | $519.48 | 29 | $0 (2024) |
| QOL Medical, LLC | $457.44 | 16 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $421.50 | 17 | $0 (2024) |
| Gilead Sciences, Inc. | $352.37 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,557 | 78 | ABBVIE INC. ($528.30) |
| 2023 | $1,543 | 84 | ABBVIE INC. ($501.22) |
| 2022 | $1,708 | 91 | ABBVIE INC. ($531.66) |
| 2021 | $1,141 | 60 | AbbVie Inc. ($486.97) |
| 2020 | $134.54 | 8 | AbbVie Inc. ($50.44) |
| 2019 | $2,287 | 26 | Allergan Inc. ($1,873) |
| 2018 | $8,948 | 53 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($6,463) |
| 2017 | $13,724 | 50 | Allergan Inc. ($7,411) |
All Payment Transactions
450 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: VIROLOGY | ||||||
| 12/11/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $77.29 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Gastroenterology | ||||||
| 10/28/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $30.73 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/21/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $122.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Immunology | ||||||
| 09/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: VIROLOGY | ||||||
| 08/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Rare Disease | ||||||
| 08/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: CRITICAL CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,452 | 1,648 | $1.6M | $331,515 |
| 2022 | 19 | 1,508 | 1,695 | $1.6M | $323,052 |
| 2021 | 20 | 1,601 | 1,823 | $1.4M | $287,250 |
| 2020 | 29 | 1,406 | 1,600 | $426,408 | $139,417 |
Total Patients
5,967
Total Services
6,766
Medicare Billing
$1.1M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Office | 2023 | 81 | 82 | $282,490 | $65,765 | 23.3% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 132 | 270 | $231,930 | $56,060 | 24.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 126 | 126 | $172,872 | $41,934 | 24.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 254 | 270 | $310,500 | $41,385 | 13.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 181 | 181 | $239,644 | $39,751 | 16.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 291 | 291 | $95,157 | $30,665 | 32.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Office | 2023 | 33 | 33 | $49,995 | $10,659 | 21.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 40 | 40 | $40,920 | $7,345 | 18.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 25 | 25 | $17,050 | $6,490 | 38.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 19 | 19 | $12,958 | $5,577 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 49 | $12,519 | $4,437 | 35.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 73 | 78 | $89,700 | $4,292 | 4.8% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 17 | 17 | $11,152 | $2,723 | 24.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $25,156 | $2,523 | 10.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 26 | $6,838 | $2,488 | 36.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 40 | $5,600 | $2,422 | 43.3% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Office | 2023 | 17 | 17 | $8,755 | $2,183 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 34 | $6,086 | $2,022 | 33.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 15 | 15 | $18,630 | $1,551 | 8.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,504 | $1,243 | 35.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Office | 2022 | 79 | 83 | $285,935 | $71,842 | 25.1% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 80 | 206 | $176,954 | $41,796 | 23.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 373 | 373 | $121,425 | $41,147 | 33.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 160 | 160 | $211,840 | $33,735 | 15.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 215 | 225 | $258,750 | $33,442 | 12.9% |
About Dr. Rafiul Islam, MD
Dr. Rafiul Islam, MD is a Gastroenterology healthcare provider based in Lubbock, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2008. The National Provider Identifier (NPI) number assigned to this provider is 1043473820.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rafiul Islam, MD has received a total of $31,044 in payments from pharmaceutical and medical device companies, with $1,557 received in 2024. These payments were reported across 450 transactions from 40 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($10,200).
As a Medicare-enrolled provider, Islam has provided services to 5,967 Medicare beneficiaries, totaling 6,766 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Lubbock, TX
- Active Since 07/02/2008
- Last Updated 01/14/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1043473820
Products in Payments
- XIFAXAN (Drug) $11,605
- LINZESS (Drug) $9,016
- VIBERZI (Drug) $2,381
- Overstitch (Device) $1,065
- MAVYRET (Drug) $541.89
- ENTYVIO (Biological) $495.63
- RINVOQ (Biological) $415.10
- DUPIXENT (Biological) $409.83
- CREON (Drug) $286.22
- INJECTAFER (Drug) $279.94
- SUCRAID (Drug) $262.78
- OVERSTITCH (Device) $258.59
- STELARA (Biological) $219.57
- ZEPOSIA (Drug) $212.65
- Sucraid (Drug) $194.66
- SKYRIZI (Biological) $186.94
- HUMIRA (Biological) $175.66
- GATTEX (Drug) $152.45
- XELJANZ (Drug) $145.73
- REMICADE (Biological) $136.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lubbock
Dr. Hamed Shabaneh Al-Tamimi, M.d, M.D
Gastroenterology — Payments: $60,450
Gastroenterology $60,450
Houssam Al Kharrat, Md, MD
Gastroenterology — Payments: $25,362
Gastroenterology $25,362
Dr. Justin Mccarthy, M.d, M.D
Gastroenterology — Payments: $12,669
Gastroenterology $12,669
Ariwan Rakvit, Md, MD
Gastroenterology — Payments: $8,630
Gastroenterology $8,630
Dr. Boyd Fenton, M.d, M.D
Gastroenterology — Payments: $8,591
Gastroenterology $8,591
Dr. Kelly Kensing, M.d, M.D
Gastroenterology — Payments: $8,390
Gastroenterology $8,390